pyrrolidine dithiocarbamate has been researched along with triclabendazole in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YK; Hsu, YJ; Lee, MC; Lin, BR; Tsai-Wu, JJ | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and triclabendazole
| Article | Year |
|---|---|
Zinc supplementation augments the suppressive effects of repurposed NF-κB inhibitors on ACE2 expression in human lung cell lines.
Topics: Angiotensin-Converting Enzyme 2; Antiparasitic Agents; Cell Line; COVID-19; COVID-19 Drug Treatment; Down-Regulation; Drug Repositioning; Emetine; Humans; Lung; NF-kappa B; Pyrrolidines; Thiocarbamates; Triclabendazole; Zinc | 2021 |